Purchase Order VA25717P0752
- Not listed
- This is a firm fixed-price purchase order contract awarded by the Department of Veterans Affairs (VA) Veterans Health Administration to Roche Diagnostics Corporation, a foreign-owned, for-profit manufacturer of in vitro diagnostics, reagents, and laboratory equipment. The $2,570,023.23 contract is for the provision of histology services and does not have a set-aside designation. Roche Diagnostics has extensive experience as both a prime contractor and subcontractor providing critical medical...
- This is a $1,799,245.83 firm fixed-price purchase order awarded by the Department of Veterans Affairs (VA) to Roche Diagnostics Corporation, a foreign-owned manufacturer of in vitro diagnostics, reagents, and related medical products. The contract is for the delivery of unspecified REAGENTS with an ultimate completion date of August 10, 2024. Roche Diagnostics is an experienced federal contractor, holding multiple Indefinite Delivery Contracts (IDCs) and Blanket Purchase Agreements (BPAs) across...
- This $400,865.87 firm fixed price purchase order was awarded by the U.S. Department of Veterans Affairs (VA) to Roche Diagnostics Corporation, a manufacturer and distributor of in vitro diagnostics, reagents, laboratory instruments, and associated products and services. The contract, which does not have a set-aside designation, is for cost per test services. Roche Diagnostics has a history of providing critical care analyzers, reagents, test kits, and other laboratory equipment and supplies to...
- The Department of Veterans Affairs Veterans Health Administration awarded a $138,104.24 firm-fixed-price purchase order to Roche Diagnostics Corporation for histology-related products and services. The contract has a completion date of March 31, 2019 and was not set aside for a specific socioeconomic program. Roche Diagnostics Corporation, a manufacturer and distributor of in vitro diagnostics, has received numerous federal contracts to provide critical care equipment, reagents, and associated...
- The Department of Veterans Affairs Veterans Health Administration awarded a firm fixed-price purchase order to Roche Diagnostics Corporation, a foreign-owned for-profit manufacturer of in vitro diagnostics, reagents, and laboratory equipment. The $157,436.96 contract, which did not have a set-aside designation, was for immunohistochemistry products and services. Roche Diagnostics has been awarded numerous federal contracts to provide medical equipment, supplies, and services to agencies such...
- This is a Firm Fixed Price delivery order awarded by the Veterans Integrated Service Network 6 (VISN 6) of the U.S. Department of Veterans Affairs (VA) to Roche Diagnostics Corporation, a foreign-owned for-profit manufacturer of in vitro diagnostics, reagents, and laboratory instruments. The $4,166.40 contract is for an annual service agreement with a completion date of December 31, 2024. Roche Diagnostics is not a set-aside awardee for this contract. The contract is part of Roche's existing...
- The Department of Veterans Affairs Veterans Health Administration awarded a $145,302.70 firm fixed-price delivery order to Roche Diagnostics Corporation, a foreign-owned, for-profit manufacturer of in vitro diagnostics, reagents, and laboratory instruments, for histology staining systems. This order was not set aside for any type of small business. Roche Diagnostics has provided critical care analyzers, reagents, test kits, and associated laboratory equipment, supplies, and services to various...
- This is a $400,033 firm fixed price purchase order awarded by the Veterans Integrated Service Network 22 (VISN 22) of the U.S. Department of Veterans Affairs to Roche Diagnostics Corporation, a foreign-owned for-profit manufacturer of medical diagnostic products and equipment. The contract is for the delivery of reagents, with a period of performance through August 10, 2025. Roche Diagnostics has previously received other prime and subcontract awards from the VA, Department of Defense,...
- This is a $92,104.71 firm fixed price purchase order contract awarded by the Department of Veterans Affairs (VA) to Roche Diagnostics Corporation, a manufacturer and distributor of in vitro diagnostics, reagents, laboratory instruments, and associated products and services. The contract is for the renewal of a lab supply test requirement, with a period of performance through May 2020. Roche Diagnostics has been awarded multiple VA, Department of Defense, and other federal agency contracts to...
- This firm fixed-price purchase order was awarded by the Department of Veterans Affairs (VA) to Roche Diagnostics Corporation, a foreign-owned for-profit manufacturer of in vitro diagnostics, reagents, laboratory instruments, and associated products and services. The $116,048.25 contract provides Roche Diagnostics' reagents for the VA's Veterans Health Administration facilities. Roche Diagnostics has a history of providing critical care medical equipment, reagents, and testing services to federal...
This is a firm fixed-price purchase order awarded by the Veterans Integrated Service Network 17 (VISN 17) of the U.S. Department of Veterans Affairs (VA) to Roche Diagnostics Corporation, doing business as Roche Diagnostics Corp, for $90,407.64 in histology supplies. The contract has an ultimate completion date of March 21, 2018 and was awarded on February 7, 2017. Roche Diagnostics is a foreign-owned, for-profit manufacturer and distributor of in vitro diagnostics, reagents, laboratory instruments, and associated products and services. Through multiple General Services Administration (GSA) Schedule contracts, Roche has provided critical care analyzers, reagents, test kits, and other laboratory equipment, supplies, and services to various federal agencies, including the VA, Department of Defense, and Department of Health and Human Services. This purchase order does not utilize a set-aside designation.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| P00001 | Close Out | ($414) | 3/21/18 | |
| Not listed | Not listed | $90.8k | 2/8/17 |